Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Off-label Indications”

3 trials

Showing 3 of 3 results

Not applicableAvailableNCT03601442
What this trial is testing

Managed Access Programs for CTL019, Tisagenlecleucel

Who this might be right for
LymphomaLeukemiaOff-label Indications
Novartis Pharmaceuticals
Not applicableStudy completedNCT02654379
What this trial is testing

Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in Europe

Who this might be right for
Off-Label Use
Hoffmann-La Roche 1,408
Not applicableAvailableNCT06393660
What this trial is testing

Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)

Who this might be right for
Transplant-Related DisorderGVH - Graft Versus Host Reaction
Victor Aquino

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation